|
|
News Breaks
|
November 18, 2009
|
| 08:11 EDT |  | SNTA |
| theflyonthewall.com: | Synta Pharma presents new data on Elesclomol | | Synta Pharmaceuticals resented new data on the mechanism of action of elesclomol, a first-in-class oxidative stress inducer, at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics in Boston, MA. “Elesclomol has been shown previously to induce apoptosis in cancer cells by increasing the level of reactive oxygen species,” said Vojo Vukovic M.D., Ph.D., Chief Medical Officer, Synta Pharmaceuticals. :theflyonthewall.com |
|
|
News For SNTA From The Last 14 Days Check below for free stories on SNTA the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 7, 2012
|
| 08:27 EDT |  | SNTA |
| theflyonthewall.com: | Synta Pharmaceuticals management to meet with Lazard Capital | | Meeting to be held in the Mid-Atlantic area on February 7 hosted by Lazard Capital. :theflyonthewall.com |
|
|
|
|
|
